| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -4.65k | 110.60k | 売り | 23.77 | 105.69k | -4.22% |
| 2026-05-18 | Dr. Shehnaaz SulimanIndependent Director | -5.74k | 144.19k | 売り | 25.12 | 20.20k | -22.13% |
| 2026-05-05 | Dr. Eric CrombezChief Medical Officer & Exec. VP | -344.00 | 8.59k | 売り | 24.96 | 51.19k | -0.67% |
| 2026-05-01 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -4.68k | 116.61k | 売り | 24.90 | 110.34k | -4.07% |
| 2026-04-01 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -4.68k | 98.20k | 売り | 20.97 | 18.73k | -20.00% |
| 2026-03-06 | Ms. Karah Herdman ParschauerChief Legal Officer & Exec. VP of Corporate Affairs | -9.53k | 208.31k | 売り | 21.40 - 22.67 | 41.55k | -18.65% |
| 2026-03-02 | Mr. John Richard PinionChief Quality Operations Officer & Exec. VP of Translational Sciences | -10.03k | 228.66k | 売り | 22.80 | 84.76k | -10.58% |
| 2026-03-02 | Mr. Erik HarrisExec. VP & Chief Commercial Officer | -10.54k | 240.29k | 売り | 22.80 | 61.71k | -14.59% |
| 2026-03-02 | Dr. Emil D. KakkisFounder, President, CEO & Director | -54.40k | 1.24M | 売り | 22.80 | 2.75M | -1.94% |
| 2026-03-02 | Ms. Karah Herdman ParschauerChief Legal Officer & Exec. VP of Corporate Affairs | -8.14k | 185.48k | 売り | 22.80 | 51.08k | -13.74% |
| 2026-03-02 | Mr. Theodore A. HuizengaSenior VP, Corporate Controller & Principal Accounting Officer | -1.63k | 37.21k | 売り | 22.80 | 27.99k | -5.51% |
| 2026-03-02 | Mr. Theodore A. HuizengaSenior VP, Corporate Controller & Principal Accounting Officer | -148.00 | 3.46k | Sale to Issuer | 23.39 | 27.99k | -0.53% |
| 2026-03-02 | Dr. Eric CrombezChief Medical Officer & Exec. VP | -7.03k | 160.26k | 売り | 22.80 | 45.61k | -13.35% |
| 2026-03-02 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -10.04k | 227.54k | 売り | 22.40 - 22.80 | 23.41k | -30.02% |
| 2026-03-02 | Mr. Dennis Karl HuangChief Technical Operations Officer and Exec. VP of Gene Therapy Operations | -999.00 | 23.37k | Sale to Issuer | 23.39 | 99.46k | -0.99% |
| 2026-02-02 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -3.06k | 72.12k | 売り | 23.56 | 18.55k | -14.16% |
| 2026-01-02 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -3.15k | 71.95k | 売り | 22.84 | 21.61k | -12.72% |
| 2025-12-29 | Mr. Theodore A. HuizengaSenior VP, Corporate Controller & Principal Accounting Officer | -85.00 | 2.92k | 売り | 34.38 | 24.60k | -0.34% |
| 2025-12-10 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -3.08k | 112.09k | 売り | 36.38 | 24.76k | -11.07% |
| 2025-10-13 | Mr. Howard HornExec. VP of Corporate Strategy & CFO | -7.94k | 250.25k | 売り | 31.51 | 27.84k | -22.19% |
| 2025-09-18 | Mr. Theodore A. HuizengaSenior VP, Corporate Controller & Principal Accounting Officer | -64.00 | 1.87k | 売り | 29.17 | 24.14k | -0.26% |
| 2025-09-12 | Ms. Karah Herdman ParschauerChief Legal Officer & Exec. VP of Corporate Affairs | -2.45k | 76.37k | 売り | 31.17 | 30.93k | -7.34% |
| 2025-09-05 | Mr. Theodore A. HuizengaSenior VP, Corporate Controller & Principal Accounting Officer | -84.00 | 2.64k | 売り | 31.39 | 24.28k | -0.34% |
| 2025-06-20 | Dr. Corazon Dating SandersIndependent Director | -2.41k | 89.92k | 売り | 37.39 | 9.60k | -20.03% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。